Cargando…
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma
Immune checkpoint inhibitors (CPIs) have expanded treatment options for patients with solid tumors. Systemic corticosteroids (CSs) have an indispensable role in cancer care, but CS-related immunosuppression may counteract the CPI-driven antitumor immune response. This retrospective study investigate...
Autores principales: | Drakaki, Alexandra, Dhillon, Preet K, Wakelee, Heather, Chui, Stephen Y, Shim, Jinjoo, Kent, Matthew, Degaonkar, Viraj, Hoang, Tien, McNally, Virginia, Luhn, Patricia, Gutzmer, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553559/ https://www.ncbi.nlm.nih.gov/pubmed/33101774 http://dx.doi.org/10.1080/2162402X.2020.1824645 |
Ejemplares similares
-
Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival
por: Kamecki, Hubert, et al.
Publicado: (2023) -
Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma
por: McNally, Michelle A., et al.
Publicado: (2021) -
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
por: Faiena, Izak, et al.
Publicado: (2018) -
The Overall Survival, Complication-Free Survival, and Related Complications of Combined Tooth-Implant Fixed Partial Dentures: A Literature Review
por: Borg, Peter, et al.
Publicado: (2016) -
O.6.1-8 Exploration of health outcomes among adolescent peer leaders of a school based physical activity intervention: baseline data
por: McNally, Kathleen, et al.
Publicado: (2023)